Literature DB >> 16564275

Expression of platelet-derived growth factor and fibroblast growth factor in cryopreserved endomyocardial biopsies early and late after heart transplant.

Achim Koch1, Evgeniy Palchyk, Nikolaus Gassler, Thomas J Dengler, Andrew Remppis, Maria Pritsch, Falk-Udo Sack, Siegfried Hagl, Philipp A Schnabel.   

Abstract

BACKGROUND: Growth factors such as platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) appear to play a key role in immunologic reactions in the long-term course after heart transplant. Their expression in the early phase after transplant has been recently described. The aim of the present study was, therefore, to examine the growth factor expression in the early and later periods, up to three years after transplant in the same patient cohort.
METHODS: Right ventricular endomyocardial biopsies were obtained from 29 heart transplant recipients before implantation, after one and two weeks, and after one, two, and three years after heart transplant, and immediately frozen in liquid nitrogen. The growth factor expression was examined immunohistochemically.
RESULTS: The PDGFs were mainly expressed in vascular structures and they were less pronounced in cardiomyocytes. Especially after the first week, a significant increase was found in the expression of PDGF A and B as well as PDGF-receptors alpha and beta. In the yearly biopsies, PDGF expression was rarely found. The bFGF expression was merely weak in the later period three years after transplant and the aFGF was only expressed in the early phase. A comparison of recipients with short and long ischemic time did not reveal any significant differences in the intensity of expression.
CONCLUSIONS: The increased expression of PDGF and FGF in the first postoperative week can be interpreted as an unspecific reaction to peritransplant injury. This might be related to important reparative, angioprotective, and wound-healing processes shortly after the heart transplant had taken place. The weak expression in the later period appears to be linked to a stable transplant function and a direct influence by the immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564275     DOI: 10.1016/j.athoracsur.2005.10.045

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  2 in total

Review 1.  Growth factor therapy for cardiac repair: an overview of recent advances and future directions.

Authors:  Samuel J White; James J H Chong
Journal:  Biophys Rev       Date:  2020-07-20

2.  Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart.

Authors:  James J H Chong; Hans Reinecke; Mineo Iwata; Beverly Torok-Storb; April Stempien-Otero; Charles E Murry
Journal:  Stem Cells Dev       Date:  2013-03-26       Impact factor: 3.272

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.